Presente y futuro del tratamiento de segunda línea del cáncer de pulmón no microcítico

28 / 48

Some rationale:
• Selection of chemosensitive tumor cells under IO
exposure
• IO can modify tumor micro-environment
increasing sensitivity to chemo
• Chemotherapy can boost the immune response
Langer C, et al. Lancet 2016